REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, July 3 /PRNewswire-FirstCall/ -- Rosetta Genomics Ltd , a leading microRNA company, announced today that J. Michael French, Rosetta Genomics President, will present at CE Unterberg, Towbin Emerging Growth Opportunities Conference on Tuesday, July 10, at 11:00 am EST at the Mandarin Oriental Hotel in New York.
A live audio webcast of the presentation will be available on the “Investors” section of the company’s website, www.RosettaGenomics.com. A replay of the presentation will be available for 30 days after the conference.
About Rosetta Genomics
Rosetta Genomics is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company’s primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases. For more information please visit: www.rosettagenomics.com
Contact: Media Alan Zachary T: +1-312-944-6784 media@rosettagenomics.com Investors Juliane Snowden T: +1-212-213-0006 investors@rosettagenomics.com
Rosetta Genomics Ltd
CONTACT: Contact: Media: Alan Zachary, T: +1-312-944-6784,media@rosettagenomics.com; Investors, Juliane Snowden, T: +1-212-213-0006,investors@rosettagenomics.com
